Scarica l'app Stockscreener
90.14
4.58%
-4.33
Dopo l'orario di chiusura:
90.14
Precedente Chiudi:
$94.47
Aprire:
$93.91
Volume 24 ore:
1.17M
Relative Volume:
1.25
Capitalizzazione di mercato:
$5.17B
Reddito:
$360.35M
Utile/perdita netta:
$-149.57M
Rapporto P/E:
-30.45
EPS:
-2.96
Flusso di cassa netto:
$-81.27M
1 W Prestazione:
-6.65%
1M Prestazione:
+3.02%
6M Prestazione:
-19.67%
1 anno Prestazione:
-31.09%
Intervallo 1D:
$89.83
$94.14
Intervallo di 1 settimana:
$89.83
$97.00
Portata 52W:
$77.10
$163.71
Glaukos Corporation Stock (GKOS) Company Profile
Nome
Glaukos Corporation
Settore
Industria
Telefono
949-367-9600
Indirizzo
1 GLAUKOS WAY, ALISO VIEJO, CA
Confronta GKOS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GKOS
Glaukos Corporation
|
90.14 | 5.39B | 360.35M | -149.57M | -81.27M | -2.96 |
|
ABT
Abbott Laboratories
|
132.81 | 228.80B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
107.29 | 158.04B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
394.34 | 149.08B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.85 | 119.71B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
80.96 | 48.01B | 5.69B | 1.41B | 577.90M | 6.95 |
Glaukos Corporation Stock (GKOS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-01 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2025-02-19 | Aggiornamento | Mizuho | Neutral → Outperform |
| 2024-12-11 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-12-06 | Iniziato | UBS | Buy |
| 2024-12-02 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2024-07-10 | Downgrade | Citigroup | Buy → Neutral |
| 2024-05-06 | Aggiornamento | Jefferies | Hold → Buy |
| 2023-12-21 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2023-12-04 | Iniziato | Morgan Stanley | Equal-Weight |
| 2023-11-28 | Iniziato | Truist | Buy |
| 2023-11-08 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-06-07 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2022-12-22 | Iniziato | Mizuho | Neutral |
| 2022-12-19 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2022-12-12 | Aggiornamento | Citigroup | Neutral → Buy |
| 2022-10-14 | Ripresa | Stephens | Overweight |
| 2022-10-04 | Iniziato | Needham | Buy |
| 2022-07-12 | Aggiornamento | Stifel | Hold → Buy |
| 2022-02-03 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2022-01-19 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2022-01-18 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2021-11-03 | Aggiornamento | Stephens | Equal-Weight → Overweight |
| 2021-07-26 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2021-07-20 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2021-07-14 | Downgrade | Oppenheimer | Outperform → Perform |
| 2021-07-14 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2021-04-08 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2021-01-29 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2020-12-16 | Aggiornamento | Citigroup | Sell → Neutral |
| 2020-12-09 | Iniziato | Oppenheimer | Perform |
| 2020-11-17 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2020-10-08 | Downgrade | JP Morgan | Neutral → Underweight |
| 2020-06-15 | Iniziato | Jefferies | Hold |
| 2020-03-05 | Iniziato | Citigroup | Sell |
| 2020-02-28 | Downgrade | JP Morgan | Overweight → Neutral |
| 2020-01-06 | Aggiornamento | Berenberg | Hold → Buy |
| 2019-12-12 | Downgrade | Wells Fargo | Outperform → Underperform |
| 2019-09-30 | Downgrade | BofA/Merrill | Buy → Underperform |
| 2019-03-08 | Iniziato | BTIG Research | Neutral |
| 2018-08-30 | Iniziato | Berenberg | Hold |
| 2018-08-29 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2018-08-03 | Reiterato | Stifel | Hold |
| 2018-06-21 | Downgrade | JP Morgan | Overweight → Neutral |
| 2018-04-13 | Downgrade | Stifel | Buy → Hold |
| 2018-03-01 | Reiterato | Cantor Fitzgerald | Buy |
| 2017-03-02 | Reiterato | Cantor Fitzgerald | Overweight |
| 2017-01-06 | Aggiornamento | Stifel | Hold → Buy |
| 2016-10-27 | Iniziato | Wells Fargo | Outperform |
Mostra tutto
Glaukos Corporation Borsa (GKOS) Ultime notizie
Glaukos at Wells Fargo Conference: Strategic Growth and Market Expansion - Investing.com
Will Glaukos Corporation price bounce be sustainableJuly 2025 Earnings & Precise Buy Zone Identification - Newser
Will Glaukos Corporation rebound enough to break even2025 Market Sentiment & Weekly Watchlist for Hot Stocks - Newser
What’s the MACD signal for Glaukos CorporationProduct Launch & AI Powered Market Entry Strategies - khodrobank.com
How to recover losses in Glaukos Corporation stockPortfolio Risk Report & Daily Chart Pattern Signal Reports - Newser
Price momentum metrics for Glaukos Corporation explainedPortfolio Value Report & Reliable Price Breakout Alerts - Newser
Tools to assess Glaukos Corporation’s risk profileTrade Entry Report & High Accuracy Trade Alerts - Newser
Using RSI to spot recovery in Glaukos CorporationExit Point & Weekly Watchlist for Hot Stocks - Newser
Relative strength of Glaukos Corporation in sector analysisJuly 2025 Macro Moves & High Conviction Buy Zone Alerts - Newser
Published on: 2025-09-03 02:06:26 - Newser
Real time scanner hits for Glaukos Corporation explainedBond Market & Fast Entry and Exit Trade Plans - Newser
Custom strategy builders for tracking Glaukos CorporationTreasury Yields & Fast Entry High Yield Stock Tips - Newser
Real time breakdown of Glaukos Corporation stock performanceJuly 2025 Decliners & Reliable Volume Spike Trade Alerts - Newser
News impact scoring models applied to Glaukos Corporation2025 Key Highlights & Detailed Earnings Play Alerts - Newser
Is Glaukos Corporation a speculative investmentWeekly Risk Report & Precise Trade Entry Recommendations - khodrobank.com
Glaukos Builds Dual Growth Engines Amid Market Headwinds - Yahoo Finance
Can swing trading help recover from Glaukos Corporation lossesJuly 2025 EndofMonth & Reliable Price Breakout Alerts - Newser
Short interest data insights for Glaukos Corporation2025 Short Interest & Comprehensive Market Scan Insights - Newser
Is Glaukos Corporation benefiting from innovation trendsTrade Entry Report & Real-Time Sentiment Analysis - khodrobank.com
Is Glaukos Corporation affected by consumer sentimentEarnings Miss & Reliable Intraday Trade Plans - khodrobank.com
What analysts say about Glaukos Corporation stock outlookPortfolio Return Report & AI Powered Trade Plan Recommendations - Newser
Order Flow Trends Show Accumulation in Glaukos Corporation getLinesFromResByArray error: size == 0 - kangso.co.kr
Trend Recap: Is Glaukos Corporation benefiting from innovation trendsBuy Signal & Weekly Momentum Stock Picks - khodrobank.com
Is Glaukos Corporation still worth holding after the dipJuly 2025 PreEarnings & Reliable Breakout Stock Forecasts - Newser
Applying Wyckoff theory to Glaukos Corporation stockWeekly Trade Report & Capital Efficient Trading Techniques - Newser
Glaukos Corporation stock trend forecastJuly 2025 Catalysts & Fast Gaining Stock Strategy Reports - Newser
Glaukos Corporation Hits Oversold Level on RSI Indicator getLinesFromResByArray error: size == 0 - thegnnews.com
Will Glaukos Corporation Hold Gains Into CloseBull Run & Verified Momentum Stock Ideas - beatles.ru
Multi factor analysis applied to Glaukos CorporationGlobal Markets & AI Enhanced Trading Alerts - Newser
Detecting price anomalies in Glaukos Corporation with AI2025 Retail Activity & Technical Buy Zone Confirmations - Newser
Glaukos Corporation Azioni (GKOS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.38%
0.32%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):